Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

FDA warns of a new malfunction risk with Abbott’s MitraClip devices

When these malfunctions occur, the FDA explained, it leads to an increased risk of additional interventions.

Monkeypox update: FDA focuses on testing as cases continue to rise

The new guidance offers a validation template that can assist test developers in submitting an Emergency Use Authorization (EUA) request. 

RBMA presses CMS to amend 2023 physician fee schedule

Warning that proposed new cuts in Medicare reimbursement could afflict U.S. healthcare with “severe and permanent damage,” the Radiology Business Management Association has presented CMS with detailed recommendations for stopping such a dire scenario from arising.

Thumbnail

Outsourcing reporting during out-of-hours shifts benefits staff, but is it sustainable?

Requests for urgent CT reads during the evening, overnight and on the weekends have increased more than 10-fold, causing a negative ripple effect throughout the radiology workforce, especially among trainees. 

bone and soft tissue tumors

Radiologists' understanding of tumor 'mimics' vital when assessing bone and soft tissue lesions

Authors of the new EJR paper explained that, although most of these tumors present in a similar way—with a lump or localized pain—their origins are wide-ranging and require the use of additional imaging to characterize the lesion. 

2 data breaches—geographically distant yet chronologically close—reported in radiology

Radiology practices in Arizona and Texas have been hit by hackers.

Down Under, imaging referrers respond to government-issued overutilization notices

Upon receiving a just-the-facts letter from a federal health official, Australia’s most frequent referrers for musculoskeletal imaging significantly curbed their inclination to place these orders over the next 12 months.

Omnipaque and Visipaque still listed among the FDA's drug shortages

According to the FDA’s most recent update, some presentations will remain out of stock or backordered until January 2023. 

Displaying 6049 - 6056 of 15673
Design by Adaptive Theme